Search Results - "Khamashta, M"

Refine Results
  1. 1

    Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review by Ruiz-Irastorza, G, Ramos-Casals, M, Brito-Zeron, P, Khamashta, M A

    Published in Annals of the rheumatic diseases (01-01-2010)
    “…Antimalarial drugs (AMs), chloroquine (CQ) and hydroxychloroquine (HCQ), are frequently withdrawn in patients with lupus with either severe or remitting…”
    Get more information
    Journal Article
  2. 2
  3. 3
  4. 4

    The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies by Sciascia, S., MD, PhD, Hunt, B.J., MD, Talavera-Garcia, E., MD, Lliso, G., MD, Khamashta, M.A., MD, PhD, Cuadrado, M.J., MD, PhD

    “…Background Antiphospholipid syndrome is defined by the combination of thrombotic events and/or obstetric morbidity in patients who have tested positive…”
    Get full text
    Journal Article
  5. 5

    Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities by SCIASCIA, S., MURRU, V., SANNA, G., ROCCATELLO, D., KHAMASHTA, M. A., BERTOLACCINI, M. L.

    Published in Journal of thrombosis and haemostasis (01-12-2012)
    “…Objectives: To evaluate the clinical accuracy of antiphospholipid antibody (aPL) specificities both individually and/or in combination, in a wide cohort of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Antiphospholipid syndrome by Khamashta, M, Taraborelli, M, Sciascia, S, Tincani, A

    “…Abstract Antiphospholipid syndrome (APS) is an autoimmune condition characterized by the occurrence of thrombosis (arterial and/or venous), often multiple,…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases by Ramos-Casals, Manuel, Soto, M J, Cuadrado, M J, Khamashta, M A

    Published in Lupus (01-08-2009)
    “…The complexity of the therapeutic approach in systemic lupus erythematosus (SLE) is increased by the large number of patients who do not respond to the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Seronegative antiphospholipid syndrome by Hughes, G R V, Khamashta, M A

    Published in Annals of the rheumatic diseases (01-12-2003)
    “…[...]the diagnosis may be wrong-the patient has a different coagulopathy. [...]it may be a "laboratory" problem; conventional testing failing to pick up cases…”
    Get full text
    Journal Article
  14. 14

    Antiphospholipid syndrome and infertility by El Hasbani, G, Khamashta, M, Uthman, I

    Published in Lupus (01-02-2020)
    “…Antiphospholipid syndrome is a systemic autoimmune disease associated with obstetric complications along with vascular events affecting multiple organ systems…”
    Get full text
    Book Review Journal Article
  15. 15

    The challenge of pregnancy for patients with SLE by Ateka-Barrutia, O, Khamashta, MA

    Published in Lupus (01-10-2013)
    “…Pregnancy poses an important challenge for doctors looking after women with systemic lupus erythematosus. Knowledge about safety of medications, the effect of…”
    Get full text
    Journal Article
  16. 16

    The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe by Cervera, R, Boffa, M-C, Khamashta, MA, Hughes, GRV

    Published in Lupus (01-09-2009)
    “…The Euro-Phospholipid project started in 1999 with a multicentre, consecutive and prospective design. A total cohort of 1000 patients with antiphospholipid…”
    Get full text
    Journal Article
  17. 17

    The abdominal manifestations of the antiphospholipid syndrome by Uthman, I., Khamashta, M.

    Published in Rheumatology (01-11-2007)
    “…Objectives. To study the abdominal manifestations of the antiphospholipid syndrome (APS). Methods. We reviewed the medical literature from 1968 to 2006 using…”
    Get full text
    Journal Article Book Review
  18. 18

    Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE by Cohen, H, Doré, C J, Clawson, S, Hunt, B J, Isenberg, D, Khamashta, M, Muirhead, N

    Published in Lupus (01-09-2015)
    “…Introduction The current mainstay of the treatment of thrombotic antiphospholipid syndrome (APS) is long-term anticoagulation with vitamin K antagonists (VKAs)…”
    Get full text
    Journal Article
  19. 19

    Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines by Asherson, R A, Cervera, R, de Groot, P G, Erkan, D, Boffa, M-C, Piette, J-C, Khamashta, M A, Shoenfeld, Y

    Published in Lupus (01-01-2003)
    “…The term ‘catastrophic’ antiphospholipid syndrome (APS) is used to define an accelerated form of APS resulting in multiorgan failure. Although catastrophicAPS…”
    Get full text
    Journal Article
  20. 20

    The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe by Cervera, R, Khamashta, MA, Hughes, GRV

    Published in Lupus (01-09-2009)
    “…The Euro-lupus project provides updated information on the epidemiologic characteristics of systemic lupus erythematosus (SLE) at the change of the millennium…”
    Get full text
    Journal Article